Abstract
Many pathophysiological and therapeutic investigations on allergic pulmonary diseases have been reported using chopped lung tissue or rat peritoneal mast cells. However, there are some problems with these experimental systems. The major problem is the difference in the responsiveness of mast cells to stimuli among species or organs. In this study, reactivity of isolated human lung mast cells to immunological and non-immunological stimuli was examined. Isolated human lung mast cells showed a maximum histamine release of 47.9±11.2% at 10 μg/ml of calcium ionophore A 23187. The reaction was dependent on the concentration of calcium ionophore A 23187 and extracellular Ca2+. Compound 48/80 failed to induce histamine release from the mast cells below the concentration of 1000 μg/ml. The optimal condition for the passive sensitization of the mast cells was incubation at a final concentration of 1000 U/ml in IgE serum at 37°C for 2 hours. This treatment significantly enhanced immunological response. Maximum histamine release of 36.0±5.7% from the mast cells after passive sensitization was shown by anti-IgE. The reaction was dependent on the concentration of anti-IgE and extracelullar Ca2+. The mast cells from a patient with buckwheat allergy released histamine by treatment with anti-IgE, specific antigen, anti-IgG and anti-IgG4 in a concentration-related manner. Isoproterenol and nicardipine inhibited histamine release induced by anti-IgE in a dose-dependent manner, indicating maximum inhibition rates of 37.8±7.0% at 10-6M and 41.2±11.9% at 5 μg/ml, respectively. Scanning electron microscopic examination showed the absence of microvilli and degranulation of the intracellular contents after immunological stimulation. Acetylcholine induced significant histamine release from the mast cells at a concentration of 10-4M. These results suggest that human lung mast cells have specific reactivity to some stimuli. Further studies of human lung mast cells are required to clarify the pathogenesis of allergic pulmonary diseases.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
